Open Access Open Access  Restricted Access Subscription Access

Hepatitis D Virus Diagnosis by Isolation, Characterization, Treated with Antibodies and Evaluating the Patients

Srinivas G., Ramanjaneyulu D.V., Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, D. Kusuma Latha, Ch. Ramya Sudha, K. Sridevi, D. Gokul Shiva Balaji

Abstract


Hepatitis B virus (HBV) is necessary for the reproduction and dissemination of the hepatitis D virus (HDV), a distinct disease. Since HDV employs the HBV surface antigen as its envelope protein, it must co-infect or superinfect with HBV in order to produce illness. Compared to HBV alone, an HDV infection can clinically cause more severe liver damage. In patients with acute HBV-HDV coinfection, the sequential spread of HBV and HDV may be reflected by a biphasic course and two different peaks in blood alanine aminotransferase. Cirrhosis and liver failure may progress more quickly in cases of chronic infection of both viruses. HDV also exhibits the unusual ability to inhibit HBV replication, however the exact mechanism is still understood. Recognizing HDV infection in patients with HBV requires prompt serological testing since this coinfection requires specialized treatment strategies. This course gives participants a thorough grasp of HDV, including how it depends on HBV to spread, how coinfection manifests clinically, and the problems that can arise. By doing the proper serological tests, they learn how to diagnose patients with suspected HDV and recognize the value of early diagnosis in improving outcomes. It describes the function of an interprofessional healthcare team, involving nurses, hepatologists, and experts in infectious diseases in the provision of comprehensive care. Working with this team improves patient outcomes by guaranteeing that the challenges of controlling HBV-HDV coinfection are handled by well-coordinated efforts, individualized treatment regimens, and thorough monitoring techniques.

Full Text:

PDF

References


Rizzetto, M., Canese, M. G., Gerin, J. L., London, W. T., Sly, D. L., & Purcell, R. H. (1980). Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. Journal of Infectious Diseases, 141(5), 590–602. https://doi.org/10.1093/infdis/141.5.590

Polson, A. G., Bass, B. L., & Casey, J. L. (1996). RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature, 380(6573), 454–456. https://doi.org/10.1038/380454a0

Kiesslich, D., Crispim, M. A., Santos, C., Ferreira, F. de L., Fraiji, N. A., Komninakis, S. V., & Diaz, R. S. (2009). Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. Journal of Infectious Diseases, 199(11), 1608–1611. https://doi.org/10.1086/598959

Patel, E. U., Thio, C. L., Boon, D., Thomas, D. L., & Tobian, A. A. R. (2019). Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011–2016. Clinical Infectious Diseases, 69(4), 709–712. https://doi.org/10.1093/cid/ciy977

Liaw, Y. F., Chiu, K. W., Chu, C. M., Sheen, I. S., & Huang, M. J. (1990). Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: A prospective study. Journal of Infectious Diseases, 162(5), 1170–1172. https://doi.org/10.1093/infdis/162.5.1170

Weisfuse, I. B., Hadler, S. C., Fields, H. A., Alter, M. J., O'Malley, P. M., Judson, F. N., Ostrow, D. G., & Altman, N. L. (1989). Delta hepatitis in homosexual men in the United States. Hepatology, 9(6), 872–874. https://doi.org/10.1002/hep.1840090608

Gaeta, G. B., Stroffolini, T., Chiaramonte, M., Ascione, T., Stornaiuolo, G., Lobello, S., Sagnelli, E., Brunetto, M. R., & Rizzetto, M. (2000). Chronic hepatitis D: A vanishing disease? An Italian multicenter study. Hepatology, 32(4 Pt 1), 824–827. https://doi.org/10.1053/jhep.2000.17919

Wedemeyer, H., & Manns, M. P. (2010). Epidemiology, pathogenesis and management of hepatitis D: Update and challenges ahead. Nature Reviews Gastroenterology & Hepatology, 7(1), 31–40. https://doi.org/10.1038/nrgastro.2009.205

Negro, F., Korba, B. E., Forzani, B., Baroudy, B. M., Brown, T. L., Gerin, J. L., & Ponzetto, A. (1989). Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. Journal of Virology, 63(4), 1612–1618. https://doi.org/10.1128/JVI.63.4.1612-1618.1989

Ni, Y., Lempp, F. A., Mehrle, S., Nkongolo, S., Kaufman, C., Fälth, M., Stindt, J., Königer, C., Nassal, M., Kubitz, R., Sültmann, H., & Urban, S. (2014). Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology, 146(4), 1070–1083. https://doi.org/10.1053/j.gastro.2013.12.024

Smedile, A., Farci, P., Verme, G., Caredda, F., Cargnel, A., Caporaso, N., Dentico, P., Trepo, C., Opolon, P., Gimson, A., Vergani, D., Williams, R., & Rizzetto, M. (1982). Influence of delta infection on severity of hepatitis B. The Lancet, 320(8305), 945–947. https://doi.org/10.1016/S0140-6736(82)90939-4

Smedile, A., Dentico, P., Zanetti, A., Sagnelli, E., Nordenfelt, E., Actis, G. C., & Rizzetto, M. (1981). Infection with the delta agent in chronic HBsAg carriers. Gastroenterology, 81(6), 992–997. https://doi.org/10.1016/S0016-5085(81)80011-5

Bichko, V., Netter, H. J., Wu, T. T., & Taylor, J. (1994). Pathogenesis associated with replication of hepatitis delta virus. Infectious Agents and Disease, 3(2–3), 94–97.

Romeo, R., Del Ninno, E., Rumi, M., Russo, A., Sangiovanni, A., de Franchis, R., Ronchi, G., & Colombo, M. (2009). A 28-year study of the course of hepatitis Delta infection: A risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology, 136(5), 1629–1638. https://doi.org/10.1053/j.gastro.2009.01.062

Niro, G. A., Smedile, A., Andriulli, A., Rizzetto, M., Gerin, J. L., & Casey, J. L. (1997). The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology, 25(3), 728–734. https://doi.org/10.1002/hep.510250322

Wu, J. C., Choo, K. B., Chen, C. M., Chen, T. Z., Huo, T. I., & Lee, S. D. (1995). Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. The Lancet, 346(8980), 939–941. https://doi.org/10.1016/S0140-6736(95)91521-6

Casey, J. L., Brown, T. L., Colan, E. J., Wignall, F. S., & Gerin, J. L. (1993). A genotype of hepatitis D virus that occurs in northern South America. Proceedings of the National Academy of Sciences, 90(19), 9016–9020. https://doi.org/10.1073/pnas.90.19.9016

Aragona, M., Macagno, S., Caredda, F., Crivelli, O., Lavarini, C., Maran, E., Farci, P., Purcell, R. H., & Rizzetto, M. (1987). Serological response to the hepatitis delta virus in hepatitis D. The Lancet, 329(8531), 478–480. https://doi.org/10.1016/S0140-6736(87)91784-6

Shattock, A. G., & Morgan, B. M. (1984). Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, using serum as the delta antigen source. Journal of Medical Virology, 13(1), 73–82. https://doi.org/10.1002/jmv.1890130111

Buti, M., Esteban, R., Jardí, R., Esteban, J. I., & Guardia, J. (1986). Serological diagnosis of acute delta hepatitis. Journal of Medical Virology, 18(1), 81–85. https://doi.org/10.1002/jmv.1890180114


Refbacks

  • There are currently no refbacks.